Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds

Details for Australian Patent Application No. 2004224242 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Frick, Wendelin; Wirth, Klaus; Heinelt, Uwe; Bleich, Markus; Lang, HansJochen; Hofmeister, Armin

Agent Watermark

Pub. Number AU-B-2004224242

PCT Pub. Number WO2004/085404

Priority 103 12 963.4 24.03.03 DE

Filing date 11 March 2004

Wipo publication date 7 October 2004

Acceptance publication date 18 March 2010

International Classifications

C07D 217/16 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/085404 Priority application(s): WO2004/085404

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

18 March 2010 Application Accepted

  Published as AU-B-2004224242

15 July 2010 Standard Patent Sealed

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004224246-Method of enhancing fluorescence

2004224239-Oxamide derivatives useful as RAFkinase inhibitors